Top ▲

CREB binding protein

Click here for help

Immunopharmacology Ligand target has curated data in GtoImmuPdb

Target id: 2734

Nomenclature: CREB binding protein

Family: Non-enzymatic BRD containing proteins

Gene and Protein Information Click here for help
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human - 2442 16p13.3 CREBBP CREB binding protein
Mouse - 2441 16 A1 Crebbp CREB binding protein
Rat - 2444 10q12 Crebbp CREB binding protein
Previous and Unofficial Names Click here for help
RSTS | Rubinstein-Taybi syndrome
Database Links Click here for help
CATH/Gene3D
ChEMBL Target
Ensembl Gene
Entrez Gene
Human Protein Atlas
KEGG Gene
OMIM
Pharos
RefSeq Nucleotide
RefSeq Protein
SynPHARM
UniProtKB
Wikipedia
Selected 3D Structures Click here for help
Image of receptor 3D structure from RCSB PDB
Description:  Solution NMR structure of ischemin bound to the bromodomain of CBP.
PDB Id:  2L84
Ligand:  ischemin
Resolution:  0.0Å
Species:  Human
References:  1
Image of receptor 3D structure from RCSB PDB
Description:  Solution NMR structure showing the association of MS7072 with the bromodomain of CBP.
PDB Id:  2D82
Ligand:  MS7972
Resolution:  0.0Å
Species:  Human
References:  4
Image of receptor 3D structure from RCSB PDB
Description:  Crystal structure of the bromodomain of human CREBBP in complex with SGC-CBP30
PDB Id:  4NR7
Ligand:  SGC-CBP30
Resolution:  1.2Å
Species:  Human
References: 

Download all structure-activity data for this target as a CSV file go icon to follow link

Inhibitors
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Value Parameter Reference
I-CBP112 Small molecule or natural product Primary target of this compound Click here for species-specific activity table Hs Inhibition 6.8 pKd 5
pKd 6.8 (Kd 1.42x10-7 M) [5]
Description: Isothermal titration calorimetry (ITC) assay.
ischemin Small molecule or natural product Hs Inhibition 4.7 pKd 1
pKd 4.7 (Kd 1.9x10-5 M) [1]
Description: Binding to CBP's bromodomain (amino acid residues 1081-1197)
SGC-CBP30 Small molecule or natural product Primary target of this compound Click here for species-specific activity table Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibition 7.2 pIC50 3
pIC50 7.2 (IC50 6.9x10-8 M) [3]
compound 50 [PMID: 24313754] Small molecule or natural product Click here for species-specific activity table Hs Inhibition 6.2 pIC50 2
pIC50 6.2 (IC50 6.31x10-7 M) [2]
Immunopharmacology Comments
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses. PMID: 26261308
Immuno Process Associations
Immuno Process:  Inflammation
GO Annotations:  Associated to 1 GO processes
GO:0002223 stimulatory C-type lectin receptor signaling pathway TAS
Immuno Process:  Immune system development
GO Annotations:  Associated to 1 GO processes
GO:0045637 regulation of myeloid cell differentiation TAS
Immuno Process:  Immune regulation
GO Annotations:  Associated to 2 GO processes
GO:0002223 stimulatory C-type lectin receptor signaling pathway TAS
GO:0045637 regulation of myeloid cell differentiation TAS
Immuno Process:  Cytokine production & signalling
GO Annotations:  Associated to 1 GO processes
GO:0032481 positive regulation of type I interferon production TAS
Immuno Process:  Cellular signalling
GO Annotations:  Associated to 1 GO processes
GO:0002223 stimulatory C-type lectin receptor signaling pathway TAS
Clinically-Relevant Mutations and Pathophysiology Click here for help
Disease:  Acute myeloid leukemia with t(8;16)(p11;p13) translocation
Orphanet: ORPHA370026
Disease:  Chromosome 16p13.3 deletion syndrome
Synonyms: Rubinstein-Taybi syndrome due to 16p13.3 microdeletion [Orphanet: ORPHA353281]
OMIM: 610543
Orphanet: ORPHA353281
Disease:  Rubinstein-Taybi syndrome 1; RSTS1
Synonyms: Rubinstein-Taybi syndrome [Disease Ontology: DOID:1933]
Rubinstein-Taybi syndrome due to CREBBP mutations [Orphanet: ORPHA353277]
Disease Ontology: DOID:1933
OMIM: 180849
Orphanet: ORPHA353277

References

Show »

1. Borah JC, Mujtaba S, Karakikes I, Zeng L, Muller M, Patel J, Moshkina N, Morohashi K, Zhang W, Gerona-Navarro G et al.. (2011) A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes. Chem. Biol., 18 (4): 531-41. [PMID:21513889]

2. Fedorov O, Lingard H, Wells C, Monteiro OP, Picaud S, Keates T, Yapp C, Philpott M, Martin SJ, Felletar I et al.. (2014) [1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains. J. Med. Chem., 57 (2): 462-76. [PMID:24313754]

3. Gallenkamp D, Gelato KA, Haendler B, Weinmann H. (2014) Bromodomains and their pharmacological inhibitors. ChemMedChem, 9 (3): 438-64. [PMID:24497428]

4. Sachchidanand, Resnick-Silverman L, Yan S, Mutjaba S, Liu WJ, Zeng L, Manfredi JJ, Zhou MM. (2006) Target structure-based discovery of small molecules that block human p53 and CREB binding protein association. Chem. Biol., 13 (1): 81-90. [PMID:16426974]

5. SGC. I-CBP112 - a CREBBP/EP300-selective chemical probe. Accessed on 03/03/2015. Modified on 03/03/2015. thesgc.org, http://www.thesgc.org/chemical-probes/ICBP112

How to cite this page

Non-enzymatic BRD containing proteins: CREB binding protein. Last modified on 12/07/2018. Accessed on 04/12/2020. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2734.